Trials / Unknown
UnknownNCT05820607
Clinical Characteristics, Lifestyle and Multi-omics Analysis in Autoimmune Gastritis
Clinical Characteristics, Lifestyle and Integrated Microbiome, Metabolome, Transcriptome, Genome Analysis in Autoimmune Gastritis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 450 (estimated)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This research will be conducted nationwide in patients with autoimmune gastritis, focusing on their clinical characteristics, possible risk factors, and multi-omics analysis. Changes in gastrointestinal microbiota, host and microbial metabolism, gene transcription and biomarkers of autoimmune gastritis will be explored to provide evidence for further precise therapy of the disease.
Detailed description
Autoimmune gastritis is a chronic progressive disease that may develop into gastric cancer. However, on account of its low morbidity, atypical clinical and endoscopic manifestation, demanding technique for detection of serological markers, the diagnosis and treatment of this disease remains challenging. Therefore, there's inadequate studies focusing on its pathogenesis, metabolism, gene transcription, microbiota etc. In recent years, multi-omics analysis provides clinicians with depth and breadth understandings of diseases. This research, as well, aims at enhancing clinicians' knowledge of autoimmune gastritis to reduce the occurrence of neuroendocrine tumors, gastric cancer, pernicious anemia and other complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Microbiome, metabolome, transcriptome, genome | Fecal genome, serum metabolome, leukocyte transcriptome, gastric mucosa genome |
Timeline
- Start date
- 2022-06-19
- Primary completion
- 2023-07-01
- Completion
- 2024-07-01
- First posted
- 2023-04-19
- Last updated
- 2023-04-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05820607. Inclusion in this directory is not an endorsement.